Erythrocytes are the most transfused cell type for example in the treatment of genetic Hb pathologies such as sickle cell disease, acquired anaemias in haematological malignancy or as adjuncts to surgery [96] necessitating scalable production strategies. This evidence concerns the gene GSTM1 and sickle cell disease.